Grid computing projects supported by Big Blue announced significant progress in looking for new potential drugs in cancer treatment

http://www.cioupdate.com/features/article.php/3888281/IBM-Volunteers-Help-Locate-Anti-Cancer-Drugs.htm

NVidia to launch a touch screen Android OS PC powered by 8 core chip that runs for 25 days

NVIDIA and Notion Ink, launches ‘Adam’, a touch screen tablet at the Las Vegas Consumer Electronics Show in January 2010, a high-tech IT product that was completely developed in India, marking the country’s big entry into product development.

With NVIDIA’s Tegra system-on-chip at its heart, Adam is a device the new generation technology user dreams of. Its battery can work for 25 days. It will have only a screen and no physical key board. One can manoeuvre the cursor using the finger commands from the front or at the back. It will have a camera that can rotate to take pictures and videos, or for video chat. It can talk to other smart devices, including phones.

Tech Spec

OS                            Google Android
General                 2G , 3G Network Triband UMTS/HSDPA GSM 850/900/1800/1900
3G Network          HSDPA 1700 / 2100 / 900
Status                    Available. January 2010
Size                        Dimensions     6.3 x 9.8 x 0.6 inches , 1.7 pounds
Display                 10.1 inch display capable of displaying 1024 x 600 pixels, Full HD capability Digital Compass, Accelerometer, Proximity,     Ambient light, Water sensors
Memory
Internal                Solid State 16/32 GB storage, can be increased further with SD card
Card slot               microSD,
Data                     GPRS     Class 32
3G                         HSDPA, 10Mbps; HSUPA, 2Mbps
WLAN                   Wi-Fi 802.11 b/g, DLNA
Bluetooth              Yes, v2.1 with A2DP
Connectivity           USB, HDMI,
Sound                   a 3.5mm headphone jack and a microphone input
USB                     Yes, v2.0 microUSB
Camera                  Primary     3MP, 2576×1936 pixels,
CPU                     eight-core NVIDIA’s Tegra T20 system-on-chip
GPS                     Yes, with A-GPS support;
Battery                Standard battery, Li-Ion 1320 mAh (BL-5J)
48hrs standby on its integrated rechargeable Li-Ion battery,
8hrs of HD video playback and 16hrs of internet surfing over WiFi
25 Days on Music play

6.3 by 9.8-inch device works on Google’s Android and Mary Lou’s Pixel Qi that offers a paper display, putting no pressure on the eyes. With 1024X600 wide SVGA colour resolution, the screen contains finger-print-resistant oleophobic coating. With a capacity of up to 32 GB flash drive, it would have SD card support, a digital compass, GPS and Wi-Fi.

It can run for 25 days if one wants to listen to just music. It can run eight hours of high-definition video or 16 hours of Wi-Fi Web use, Rohan Shravan, founder and Director, Creatives, of Notion Ink, claims.

The half-inch thick device is likely to be priced at USD$ 300. The device would be connected to specially-devised servers called Genesis.

How they managed to tackle these challenges one by one could be a good case study for wannabe entrepreneurs.

With angel funding from an IT consultant, the team started looking for people to work on the project. They needed about 50 engineers, both hardware and software.

After discussions with several colleges, they tied up with BVRIT, a technology institute not very far from the Hi-Tec City, the hub of all the IT activity in Andhra Pradesh.

The arrangement was simple. Notion Ink would utilise the lab as its development centre and the students as its workforce, while the students get training in the industry-ready technologies such as Android and cloud.

“We then roped in the National Institute of Design (at the Bangalore Research and Development campus) to discuss the user interface that should go into the next generation tablet,” Shravan explains.

As some of them got down to the task of planning the design, internal architecture of the product, HR aspects and infrastructure, the remaining members of the team went to the US and Taiwan to address the hardware and manufacturing needs. While they joined hands with NVIDIA for Tegra, they teamed up with TPK for touch screens and another Original Device Manufacturer for manufacturing the complete product.

Seeing a good idea, NVIDIA offered to handhold the team. “Theirs is a brilliant idea and we have seen the burning desire in them to create an innovative product. It has got good potential in India in the fields of education, entertainment and telemedicine,” J.A. Chowdhary, Managing Director of NVIDIA India, points out.

After nearly a year’s hard work and consuming all the monies they earned for a year or two before Notion Ink, the team has not run out of steam as yet.

They are now busy testing the device with some telecom companies for cross-check connectivity issues.

“We are going to get the first batch of 60 Adams. We are in talks with content providers and have signed pacts in some segments. These tie-ups will be for content delivery and content aggregation,” Shravan says.

Looks like Notion Ink will be competing with a similar system laucnhed by Converged Devices

Android 2.0 Eclair
186mm x 158mm x 18mm
7″ Touchscreen
NVIDIA Tegra
512 DDR / 512 NAND
1.3 MP Web Cam
4GB Internal SD (non removable)
Micro SD
Bluetooth 2.1
Wireless 802.11 b/g
USB 2.0
2g/3g Data
Cellular
3.5mm Audio Jack
Accelerometer
Ambient light sensor
Dual digital microphones
FM Radio

More news

http://notionink.wordpress.com/

Myth=My sales people are wasting valuable time on Linkedin when they should be selling, Reality= Social Networking helps in Sales -Top execs say they are influenced by social networks

My sales people are wasting valuable time on Facebook and Linkedin when they should be selling”: Now thats what most sales managers would say. I know thats true , I have irritated fare share of my managers by using social media to create and close sales and in lead generation. And I continue to do it today, thanks to my current orgnaizations forward looking ways , this time around I have the support of my management to these activities.

Society for New Communications Research (SNCR) has oublished a research that shows that company executives are influenced by their online networks.

Here are some key findings from this survey 365 business professionals:

– Professional decision-making is becoming more social – enter the era of Social Media Peer Groups (SMPG)

  • Traditional influence cycles are being disrupted by Social Media as decision makers utilize social networks to inform and validate decisions
  • Professionals want to be collaborative in the decision-cycle but not be marketed or sold to online; however online marketing is a preferred activity by companies.

– Professional networks are emerging as decision-support tools

  • Decision-makers are broadening reach to gather information especially among active users

– Professionals trust online information almost as much as information gotten from in-person

  • Information obtained from offline networks still have highest levels of trust with slight advantage over online (offline: 92% – combined strongly/somewhat trust; online: 83% combined strongly/somewhat trust)

– Reliance on web-based professional networks and online communities has increased significantly over the past 3 years

  • Three quarters of respondents rely on professional networks to support business decisions
  • Reliance has increased for essentially all respondents over the past three years

– Social Media use patterns are not pre-determined by age or organizational affiliation

  • Younger (20-35) and older professionals (55+) are more active users of social tools than middle aged professionals.
  • There are more people collaborating outside their company wall than within their organizational intranet

I have also found a similarlt interesting  blog . Hosted at Sales20Book.com

“My sales people are wasting valuable time on Facebook and Linkedin when they should be selling”: Now thats what most sales managers would say. But does Social Networking help sales people sell Full Article . I liked that statement especially since it came from Microsoft executive. . As I have also faced the ire of top management for using social media in my career, some time even in Oracle. So this report is an eye opener for opponents of social media for sales.

The complete presentation and arguments are available on http://www.sales20book.com/wp/2009/05/social-networking-in-sales-show-me-the-money/

FDA Webinar Drug Marketing and Advertising Are You Prepared for the Challenges of Social Media?

Since the FDA cracked down on social media marketing and online advertising, drugmakers have been walking on eggshells. A key FDA meeting is scheduled for Nov. 12-13. Read on …

Drug Marketing and Advertising
Are You Prepared for the Challenges of Social Media?

An FDAnews Webinar
Thursday, Nov. 19, 2009 • 11:00 a.m. — 12:30 p.m. EST

Register Today!

Internet marketing and social media offer powerful new tools to communicate the benefits of your drugs and biologics. But with the FDA a threatening question mark, it’s hard to know how to move forward.

What are the best practices firms can employ while the FDA determines its approach to regulating social media and internet advertising?

Consult the experts.

Dr. Mark DeWyngaert is a leading consultant in drug sales and marketing; he helps drug and biologic makers thread through the FDA maze. Alan Bennett is managing partner in the Washington, D.C. office of Ropes & Gray and has represented clients at the FDA and in Congress on many of the critical issues that affect the pharmaceutical industry. We’ve invited them to spend 90 minutes with you, explaining what the FDA is doing, where it’s heading, and how you can meet your marketing goals — without crossing regulatory boundaries.

In 90 fast-paced minutes, without ever leaving the convenience of your office, you’ll have the opportunity to pick our experts brains — at a cost that’s a fraction of what you’d pay for an on-site consulting visit. They’ll fill you in on key points from the November public meeting and help you prepare for whatever new FDA strategies emerge. Here’s just a taste of this webinar’s agenda:

  • The 5 issues DDMAC is citing in enforcement letters
  • How current regulations and guidance apply to your particular situation
  • The 3 main types of social media: user-generated content, bookmarking and sharing, and social networking
  • What YouTube, Wikipedia, Facebook, Linked-in and Twitter have in common, and how consumers are using them
  • The 6 types of adult online consumers
  • Social media advertising trends
  • How brand reputation is affected by growing product awareness, patient interaction and portability
  • Social media tools — which are high risk, which are low risk
  • Developing an innovative social media monitoring program
  • Using social media monitoring and text mining to create models and identify consumer trends
  • And plenty more!

Because this seminar is web-based and totally interactive, you’ll have plenty of opportunity to email all your questions and receive answers before the session ends.

Advertising and marketing cut across many company departments and functions. Dozens in your company may wish to attend. That’s no problem. As many personnel may log on as you like — for one low registration fee. There are no restrictions except that all registrants must be at the same company location.

The FDA has made no bones about plans to step up enforcement, and DDMAC is at the forefront of agency plans. Now is the time to prepare. Make plans now to log on for this one-time-only session.

Who Will Benefit

  • Compliance officers
  • Sales and marketing professionals
  • Medical affairs personnel
  • General/corporate counsel
  • Regulatory/legislative affairs professionals
  • Communications/public relations professionals

Register now!

Meet Your Instructor
Dr. Mark DeWyngaert
is a managing director in the Life Sciences Advisory Practice at Huron Consulting. Trained as a molecular biologist, he specializes in assisting pharmaceutical manufacturers, biotechnology and medical device companies with identifying and mitigating regulatory risks and valuing intellectual property. As a consultant, he leads teams in the assessment of sales and marketing, medical affairs and clinical development activities, and he assists companies in the redesign of business practices to comply with regulations and standards.

Alan Bennett is managing partner in the Washington, D.C. office of Ropes & Gray and formerly served as co-chair of the firm’s Life Sciences Group. He focuses on legal issues surrounding the development and marketing of medical products and has served as outside counsel to many pharmaceutical and medical device firms. Alan’s practice at Ropes & Gray has involved counseling clients, and representing them at the FDA and in Congress, on many of the critical issues that affect the pharmaceutical industry. He is a recognized expert on issues that arise under the Hatch-Waxman Act, as well as on issues involving pharmaceutical marketing, promotion and education.

Webinar Details
Date: Thursday, Nov. 19, 2009
Location: Your office or conference room (no need to travel!)
Time: 11:00 a.m.12:30 p.m. EST
10:00 a.m. 11:30 a.m. CST
9:00 a.m.10:30 a.m. MST
8:00 a.m. 9:30 a.m. PST
4:00 p.m.5:30 p.m. GMT

Price: Webinar PLUS Audio CD and Transcript: $527 — Best Value!
You’ll have access to one log–in and dial–in for the live 90–minute webinar for unlimited participants! You’ll also receive all presentation materials and the opportunity to ask questions by phone and email, PLUS an audio CD and written transcript of the entire session.

Webinar Only: $327
You’ll have access to one log–in and dial–in for the live 90–minute webinar for unlimited participants! You’ll also receive all presentation materials and the opportunity to ask questions by phone and email.

Gather your team for maximum benefit! Your investment is for one site. Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.

Register Today!
Please mention priority code 09N06 when registering.

  1. Enroll online.
  2. Call +1 (703) 538-7600 or toll free (888) 838-5578.
    Use your American Express, Visa or MasterCard.
  3. Mail your check to: FDAnews, 300 N. Washington St., Suite 200
    Falls Church, VA 22046-3431

Can’t Attend?
Choose between the Audio CD and transcript or listening in on the Encore presentation:

  • Audio CD and Transcript Only: $327 (plus shipping and handling)
    You’ll receive an audio CD, written transcript of the entire 90-minute audioconference, including the Q&A period, and all presentation materials four weeks after the session.

  • 24/7 ENCORE™ Audio Presentation: $327
    You’ll have access to one dial-in for an archived recording of the entire 90-minute audioconference, including the Q&A period, for unlimited participants. You can dial in any time of day or night for three weeks, from Nov. 23 – Dec. 11, 2009. You’ll also receive all presentation materials.

FDAnews offers a variety of webinars and audioconferences to keep you and your staff current on today’s most important regulatory, legislative and business issues. Click here to view a complete list of the topics available and register today.

Interested in Becoming a Speaker?
We’re always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.

Blogging and complying with FDA and other medical device regulations

Blogging and complying with FDA and other medical device regulations – how to safely generate a corporate blog for a medical device company?

Given that marketing communications for medical device companies are tightly regulated, I wonder how realistic it is for a medical device company to generate a blog. Would love to hear from anyone that has experience or a perspective.

My answers are on Linkedin

http://www.linkedin.com/answers/marketing-sales/search-marketing/MAR_SRC/466277-10937?browseIdx=0&sik=1240994405907&goback=.ama

3G Doctor

I am working on the topic (software as a service) SaaS applications in Medical and Healthcare field, so the next few months my focus there.

So this week I like to post about 3GDoctor.com a service that allows you to video consult with General Medical Council registered Doctors using a 3G Video Mobile. When you register as a patient with 3G Doctor you can also use it to create, store and manage your Personal Health Record which can be referred to by your Doctor during video consultations. Yummy now that feels like the next google acqusition target.

Mediserve is another company that is now planning to came up with SaaS model of their applications.

And of course have to talk about Microsoft , even though I work for Oracle andicrosoft is competition.

Digipede is developing on microsofts .net plafrom to help anyone providing SaaS on the Microsoft platform. And they claim to have a bioinformatics company testing their application to develop bioinformatics application in SaaS model And it lok like that customer is The Friedrich Miescher Institute (FMI) as a part of the Novartis Research Foundation, details of the case study on Digipede website

And yes I ahve written about  GeneBio earlier their claims to have PhenyxOnline as the first commercial platform in the proteomics field offered in a SaaS model    

Also came across this intersting post by Paweł Szczęsny.  Thinking about RaaS: Research-as-a-Service

Physician digital marketing & sales trends webcast

Taking the Pulse® U.S. — Physicians and Emerging Information Technologies, is a syndicated multi-client physician research study and advisory service focused on understanding technology adoption and integration trends among U.S. practicing physicians. Now in its seventh year, the primary objective of the research study is to track which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future.

Taking the Pulse® v8.0 was fielded in Q1 2008 among 1,832 practicing U.S. physicians. Covering subjects that ranges from

  • General Access and Technology Profile: Practice technology profile, frequency of Internet use, frequency of professional activities online
  • Online and Offline Professional Information Sources: Online and offline information sources used, including textbooks, journals, CME, reps, search engines, sites visited, conditions researched
  • Detailing and Pharma Services: eDetailing participation and future interest, use and interest in full-service portals, product and corporate site visitation, rep technology usage
  • Web 2.0 Technologies: Awareness and use of streaming video, blogs, podcasting and social networking, including use of sites such as Sermo
  • Email Use and Opportunity: Email newsletters, email with patients, colleagues, and pharmaceutical, biotech or device companies
  • Patient Interaction and Education: Patients bringing information into office, sites recommended to patients, types of patient education sources of interest
  • Digital Health Infrastructure: ePrescribing, EMR, Practice Management, Speed of Access
  • Mobile Technology Profile: PDA, Mobile Phone, Internet, Mobile Integration, iPods, MP3 players and tablet PCs

The Webinar is on June 5 2008, by Manhattan Research about physician digital marketing & sales trends webcast –register at manhattanresearch.webex.com

Note: as is from manhattanresearch website

%d bloggers like this: